Leads sourcing strategy, contracting, and supplier governance for clinical operations and trial supply partners, optimizing vendor performance, study spending, and operational execution across a global clinical portfolio.
Leads and contributes to hematology and oncology clinical study design and execution, partnering across teams to author regulatory documents, interpret clinical data, monitor safety, and support study delivery and scientific communications.
Provides medical leadership across oncology medical affairs and clinical development, overseeing pivotal trials, shaping product strategy, guiding safety and regulatory work, and engaging investigators and scientific stakeholders.
Lead payer account strategy for oncology products by building relationships with national and regional payers, influencing coverage and reimbursement, and coordinating cross-functional efforts to improve patient access and affordability.
Leads analytics strategy and performance excellence across a global clinical trial portfolio, turning operational data into insights that strengthen study execution, portfolio oversight, data governance, and risk-based decisions.
The Corporate Counsel, Clinical Contracts will support the review, negotiation, and execution of contracts across various departments, ensuring compliance and minimizing risk.
Leads preparation and review of clinical and regulatory documents for a clinical development program, coordinating cross-functional input and timelines while ensuring accuracy and compliance with US and ex-US requirements.
Leads global clinical trial site agreement strategy, negotiating budgets and contracts, forecasting payments, and partnering across clinical, legal, finance, CRO, and site teams to enable timely study activation.
Leads complex, high-priority regulatory programs and submissions across the product portfolio, aligning cross-functional teams, guiding executive decisions, and strengthening program governance and organizational capability.
Oversee global pharmacovigilance operations across clinical and post-market programs, managing outsourced safety activities, vendor governance, regulatory compliance, inspection readiness, and safety systems.
Oversee global clinical trials from startup through closeout, coordinating sites and CROs, monitoring performance and data quality, managing operational risks, and ensuring regulatory compliance and inspection readiness.
Provides strategic and operational leadership for complex global oncology trials, overseeing study execution from protocol development through closeout while driving quality, compliance, data integrity, and inspection readiness.
Leads operational strategy and execution for global oncology clinical trials, managing teams and vendors while ensuring compliant, on-time delivery through risk oversight, budget accountability, and cross-functional collaboration.
The Senior Director, Regulatory CMC will lead the development of regulatory strategies and submissions for Summit's biologics, ensuring compliance and effective collaboration across teams.
The National Accounts Director for Government Payers – Medicaid will lead efforts to secure access and reimbursement for oncology products through strategic relationships and management of Medicaid accounts.
The Senior Medical Science Liaison supports oncology therapeutic-area objectives by engaging healthcare professionals, communicating scientific evidence, educating clinicians, and contributing to clinical development and research.
The Senior Medical Science Liaison supports oncology therapeutic areas by engaging healthcare professionals, sharing scientific education, supporting clinical research, and translating field insights into medical and business plans.
Leads scientific engagement across an assigned oncology territory, educating healthcare professionals, building expert relationships, supporting clinical research, and translating scientific insights into medical and account plans.
The Director, Value Outcomes Liaison will engage with US population-based decision makers to educate them on the clinical and economic impact of ivonescimab, facilitating access and improving patient outcomes.
The Director, Value Outcomes Liaison (VOL) will engage with US population-based decision makers to educate them on the clinical and economic impact of ivonescimab, enhancing access and improving patient outcomes.
The Senior Director of Regional Medical Science leads a national team of Medical Science Liaisons, ensuring high-quality scientific engagement and strategic execution in oncology.
The Director, Safety Physician will oversee pharmacovigilance activities, ensuring the safety of investigational and marketed products through medical oversight and compliance with regulatory requirements.
The Senior Director of Regulatory Affairs will develop global strategies for IND/CTA approvals and lead regulatory efforts for marketing applications in oncology.
The Director of Market Access Payer Accounts will lead relationships with national and sub-national payers to ensure access, reimbursement, and affordability for oncology products.
Page 1 · 27 results
